BlackSky to Host Second Quarter 2025 Results Conference Call — Neutral
BKSY Business Wire — July 21, 2025HERNDON, Va.--(BUSINESS WIRE)---- $BKSY #earnings--BlackSky Technology Inc. (NYSE: BKSY) will host a conference call to discuss second quarter 2025 financial results and its business outlook on Thursday, August 7, 2025, at 8:30 a.m. EDT. A press release with BlackSky's financial results will be released in advance of the conference call that same day. To access the live webcast or the archived webcast following completion of the call, please click here or visit the company's investor relations website at http://ir.

BKV Corp. Expands Strategic Partnership with Leading Midstream Operator to Advance Carbon Capture and Sequestration Development — Neutral
BKV Business Wire — July 21, 2025DENVER--(BUSINESS WIRE)--BKV Corporation (“BKV” or the “Company”) (NYSE: BKV) today announced the execution of an agreement with a leading diversified midstream energy company to develop a new carbon capture and sequestration (“CCS”) project at a currently operating natural gas processing plant in East Texas. The agreement expands on a previously announced agreement between the companies to develop a separate CCS project at a location in South Texas. The new CCS project will be constructed on t.

Phase 3 OASISplus data demonstrating benefit of donidalorsen for HAE patients who switched from other prophylactics published in JACI In Practice — Neutral
IONS Business Wire — July 21, 2025CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that positive results from the Phase 3 OASISplus prospective switch study of donidalorsen in patients with hereditary angioedema (HAE) were published in The Journal of Allergy and Clinical Immunology (JACI) In Practice. Results indicate that patients who switched to donidalorsen from prior prophylactic treatments showed a 62% further reduction in mean monthly HAE attack rate from baseline, and 84% of p.

Compugen Announces First Patient Dosed in COM701 Global Platform Trial in Platinum Sensitive Ovarian Cancer — Neutral
CGEN PRNewsWire — July 21, 2025Randomized sub-trial 1 of a global adaptive platform trial of COM701 maintenance therapy in patients with relapsed platinum sensitive ovarian cancer Trial supported by strong biological rationale and clinical data from patients with advanced ovarian cancer Interim analysis planned for the second half of 2026 HOLON, Israel , July 21, 2025 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery powered by AI/ML, today announced that the first patient was dosed in the global randomized sub-trial 1 of adaptive platform trial, MAIA-ovarian (which stands for MA intenance Immunotherapy …

Tiziana Life Sciences Announces Immunologic Analysis of Nasal Foralumab in Moderate Alzheimer's Patient — Neutral
TLSA GlobeNewsWire — July 21, 2025NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced compelling immunologic findings from the treatment of a moderate Alzheimer's Disease (AD) patient with intranasal foralumab.

WEBUY GLOBAL LTD. Launches Groundbreaking AI Travel Assistant Device Powered by DeepSeek V3 Model and Espressif's ESP32-C — Neutral
WBUY GlobeNewsWire — July 21, 2025Singapore, July 21, 2025 (GLOBE NEWSWIRE) -- WEBUY GLOBAL LTD. (Nasdaq: WBUY) (“Webuy” or the “Company”), a leading innovator in travel technology and retail solutions, is proud to announce the launch of its groundbreaking AI Travel Assistant—a wearable device poised to redefine the travel experience for millions of global travelers.

Amicus Therapeutics to Announce Second Quarter 2025 Financial Results on July 31, 2025 — Neutral
FOLD GlobeNewsWire — July 21, 2025PRINCETON, N.J., July 21, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, July 31, 2025, at 8:30 a.m.

RACINE, Wis. , July 21, 2025 /PRNewswire/ -- Modine (NYSE: MOD), a diversified global leader in thermal management technology and solutions, announced today that Alan Lowe joined the Company's Board of Directors effective July 18, 2025.

NewGen Subsidiary Signs Memorandum of Understanding with Prominent UAE Real Estate Developer — Neutral
NIVF GlobeNewsWire — July 21, 2025The agreement with BNW Real Estate Development LLC positions NewGenDigital to maximize the profitability of its recently acquired plot of land in the UAE

Globe Life Inc. Announces Second Quarter 2025 Earnings Release and Conference Call — Neutral
GL PRNewsWire — July 21, 2025MCKINNEY, Texas , July 21, 2025 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) will announce its Second Quarter 2025 financial results after the market closes on Wednesday, July 23, 2025. At that time, a copy of the Company's Second Quarter 2025 earnings press release and any other financial and statistical information about the quarter will be available on the Company's website, https://investors.globelifeinsurance.com/, under Financial Reports and Other Financial Information.

SriLankan Cargo Joins Freightos: New Digital Bridge to South Asian Markets — Neutral
CRGO PRNewsWire — July 21, 2025BARCELONA, Spain , July 21, 2025 /PRNewswire/ -- Freightos (NASDAQ: CRGO), the leading digital booking and payment platform for the international freight industry, today announced that SriLankan Cargo, the air freight arm of SriLankan Airlines, has partnered with WebCargo for online air cargo booking and payments. This partnership, which is planned to go live later this quarter, significantly strengthens Freightos' footprint in South Asia and unlocks digital access to Colombo—a growing transshipment hub linking the Indian subcontinent with the Middle East, Southeast Asia, and Europe.

Guaranty Bancshares, Inc. Reports Second Quarter 2025 Financial Results — Neutral
GNTY Business Wire — July 21, 2025ADDISON, Texas--(BUSINESS WIRE)-- #gnty--Guaranty Bancshares, Inc. (NYSE: GNTY) (the "Company," "we," "us," or "our"), the parent company of Guaranty Bank & Trust, N.A. (the "Bank"), today reported financial results for the fiscal quarter ended June 30, 2025. The Company's net income available to common shareholders was $10.0 million, or $0.88 per basic share, for the quarter ended June 30, 2025, compared to $8.6 million, or $0.76 per basic share, for the quarter ended March 31, 2025 and $7.4 milli.

Verizon Raises Earnings Guidance. There's Still One Worry for Investors. — Positive
VZ Barrons — July 21, 2025The wireless carrier hiked its outlook for earnings per share and free cash flow on Monday.

Funko to Host 2025 Second Quarter Financial Results Conference Call on Thursday, August 7, 2025 — Neutral
FNKO Business Wire — July 21, 2025EVERETT, Wash.--(BUSINESS WIRE)--Funko, Inc. (Nasdaq: FNKO), a leading pop culture lifestyle brand, today announced that it will host a conference call on Thursday, August 7, 2025, at 4:30 p.m. ET to discuss its financial results for the second quarter ended June 30, 2025. The conference call will be webcast and can be accessed on the investor relations section of the Funko website at https://investor.funko.com. After the call, a replay of the webcast will be available on the same website. Abou.

Pediatrix Medical Group 2025 Second Quarter Conference Call/Webcast Scheduled for Tuesday, August 5, 2025 — Neutral
MD Business Wire — July 21, 2025FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2025 Second Quarter Conference Call/Webcast Scheduled for Tuesday, August 5, 2025.

Agrees to issue approximately $10 Million Convertible Notes at $13 per share, a 198% premium to July 18 close $189 million raised year-to-date through hallmark DeFi/TradFi Accretion Flywheel strategy SILVER SPRING, MD, July 21, 2025 (GLOBE NEWSWIRE) -- BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a blockchain technology-focused company, short for Blockchain Technology Consensus Solutions, today announced that the combined market value of its 55,788 ETH holdings, cash1, and other liquid holdings are approximately $242.2 million, based on an ETH price of $3,600. Additionally, the Company has agreed to issue $10 million in convertible notes through its previously established …

Oruka Therapeutics Announces IND Clearance for EVERLAST-A Phase 2a Trial of ORKA-001 in Psoriasis with Phase 1 Data to be Presented at EADV in September — Neutral
ORKA GlobeNewsWire — July 21, 2025IND cleared for the EVERLAST-A Phase 2a trial of ORKA-001 in moderate-to-severe psoriasis, with initial data expected 2H 2026

BioCryst to Report Second Quarter 2025 Financial Results on August 4 — Neutral
BCRX GlobeNewsWire — July 21, 2025RESEARCH TRIANGLE PARK, N.C., July 21, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its second quarter 2025 financial results on Monday, August 4, 2025.

BioXcel Therapeutics Submits Pre-Supplemental New Drug Application Meeting Package in Support of Potential Label Expansion for IGALMI® — Neutral
BTAI GlobeNewsWire — July 21, 2025Company focused on obtaining approval for outpatient (at-home) use of IGALMI® for the acute treatment of agitation associated with bipolar disorders or schizophrenia

Beneficient Appoints Tom Hicks as Chairman and James Silk as Interim Chief Executive Officer — Neutral
BENF GlobeNewsWire — July 21, 2025DALLAS, July 21, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ: BENF) (“Ben” or the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform AltAccess, today announced the separation of the roles of Chairman of the Board of Directors (“Board”) and Chief Executive Officer with the appointment of Thomas O. Hicks as Chairman of the Board and James G.
